Moreover, comparing aggressive grade II or III meningiomas with grade I tumors, loss of Zo-1 and E-Cadherin together with increased expression of Zeb-1 and Slug were observed, indicating that molecular features of EMT are present in aggressive meningiomas [101]. The gene discussed is CDH1; the disease is meningioma.